Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Marr

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
British Journal of Cancer|October 21, 2020
Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemiaTimothy M Barrow, Sirintra Nakjang, Fadhel Lafta, et al.
British Journal of Haematology|June 25, 2026
CD19 chimeric antigen receptor T-cell efficacy and toxicity in adults with Richter's transformation and response to bridging therapyAngela Hwang, Amy A Kirkwood, Maeve O'Reilly, et al.
Blood Advances|October 25, 2019
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemiaPaul Milne, Charlotte Wilhelm-Benartzi, Michael R Grunwald, et al.
Haematologica|February 17, 2018
Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21Paul B Sinclair, Helen H Blair, Sarra L Ryan, et al.
British Journal of Haematology|February 16, 2019
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysisToby A Eyre, Amy A Kirkwood, Sat Gohill, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Blood Advances|April 29, 2026
Acalabrutinib monotherapy as a first-line treatment for CLL: 3 years follow-up of the real-world EPIC studyToby A Eyre, Nicolás Martínez-Calle, Shankara Paneesha, et al.
Nature Communications|January 29, 2021
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemiaWei-Yu Lin, Sarah E Fordham, Nicola Sunter, et al.
Blood Advances|December 21, 2023
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK studyAnn Tivey, Rohan Shotton, Toby A Eyre, et al.
Nature Communications|February 7, 2017
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemiaPhilip J Law, Sonja I Berndt, Helen E Speedy, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Journal of Cancer|October 21, 2020
Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemiaTimothy M Barrow, Sirintra Nakjang, Fadhel Lafta, et al.
British Journal of Haematology|June 25, 2026
CD19 chimeric antigen receptor T-cell efficacy and toxicity in adults with Richter's transformation and response to bridging therapyAngela Hwang, Amy A Kirkwood, Maeve O'Reilly, et al.
Blood Advances|October 25, 2019
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemiaPaul Milne, Charlotte Wilhelm-Benartzi, Michael R Grunwald, et al.
Haematologica|February 17, 2018
Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21Paul B Sinclair, Helen H Blair, Sarra L Ryan, et al.
British Journal of Haematology|February 16, 2019
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysisToby A Eyre, Amy A Kirkwood, Sat Gohill, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Blood Advances|April 29, 2026
Acalabrutinib monotherapy as a first-line treatment for CLL: 3 years follow-up of the real-world EPIC studyToby A Eyre, Nicolás Martínez-Calle, Shankara Paneesha, et al.
Nature Communications|January 29, 2021
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemiaWei-Yu Lin, Sarah E Fordham, Nicola Sunter, et al.
Blood Advances|December 21, 2023
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK studyAnn Tivey, Rohan Shotton, Toby A Eyre, et al.
Nature Communications|February 7, 2017
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemiaPhilip J Law, Sonja I Berndt, Helen E Speedy, et al.
Pageof 2